Inseego (INSG) director receives 9,427 RSUs vesting 09/10/2026
Rhea-AI Filing Summary
Jeffrey Tuder, a director of Inseego Corp. (INSG), reported a grant of 9,427 restricted stock units (RSUs) on 09/12/2025 that settle 1-for-1 into common shares and carry a $0 acquisition price. After the grant, the filing shows Mr. Tuder beneficially owned 64,717 shares of common stock. The RSUs are scheduled to vest on 09/10/2026.
The Form 4 was executed on behalf of the reporting person by an attorney-in-fact and dated 09/16/2025. The filing discloses a non-derivative transaction only and provides no additional compensation terms, tax elections, or hedging arrangements.
Positive
- Director received RSUs which align management interests with shareholders through equity ownership
- RSUs vest one year from grant (09/10/2026), providing a retention incentive
Negative
- Form does not disclose whether RSUs are performance-based or include change-in-control protections
- No total share count or percentage ownership is provided, so dilution impact cannot be assessed from this filing alone
Insights
TL;DR: Director received equity-based compensation of 9,427 RSUs that vest in one year, modestly increasing insider ownership.
The grant of 9,427 RSUs at $0 is a common form of director/equity compensation that aligns the director's interests with shareholders through deferred equity. The filing shows total beneficial ownership of 64,717 shares, indicating the grant increases but does not appear to create majority control. Key governance points not disclosed in the form include whether the grant was part of an annual director compensation plan or performance-based, and whether there are forfeiture or change-in-control provisions. Absence of cash consideration and the one-year vesting schedule are typical for RSU awards to board members.
TL;DR: Non-cash RSU award increases insider stake; no sale or dilution details provided.
The transaction is categorized as an acquisition (code A) of RSUs that convert 1-for-1 into common stock on vesting. Because exercise/strike price is $0 and there is no immediate share issuance, this is a future dilution risk when RSUs vest and shares are issued. The filing does not state the total shares outstanding, so the percentage dilution from 9,427 RSUs cannot be calculated from this form alone. No derivative instruments, dispositions, or hedges were reported alongside the award.